Connection

Barbara Tilley to Aged

Back to Details
This is a "connection" page, showing publications Barbara Tilley has written about Aged.
Barbara Tilley
Connection Strength
0.600
Aged
  1. Analysis of transtheoretical model of health behavioral changes in a nutrition intervention study--a continuous time Markov chain model with Bayesian approach. Stat Med. 2015 Nov 30; 34(27):3577-89.
    View in: PubMed
    Score: 0.042
  2. Unequal burden of disease, unequal participation in clinical trials: solutions from African American and Latino community members. Health Soc Work. 2013 Feb; 38(1):29-38.
    View in: PubMed
    Score: 0.036
  3. Repeatable battery for assessment of neuropsychological status in early Parkinson's disease. Mov Disord. 2009 Jul 30; 24(10):1453-60.
    View in: PubMed
    Score: 0.028
  4. Factor analysis of the Repeatable Battery for the Assessment of Neuropsychological Status. Appl Neuropsychol. 2008; 15(4):274-9.
    View in: PubMed
    Score: 0.025
  5. A study of lower extremity amputation rates in older diabetic South Carolinians. J S C Med Assoc. 2007 Feb; 103(1):4-7.
    View in: PubMed
    Score: 0.023
  6. English language skills and diabetes and hypertension among foreign-born South Asian adults in England. Public Health Rep. 2006 May-Jun; 121(3):331-6.
    View in: PubMed
    Score: 0.022
  7. Demographic and clinical factors associated with in-hospital death among patients with systemic sclerosis. J Rheumatol. 2005 Oct; 32(10):1888-92.
    View in: PubMed
    Score: 0.021
  8. A pilot study of health education via a nurse-run telephone self-management programme for elderly people with osteoarthritis. J Telemed Telecare. 2004; 10(1):44-9.
    View in: PubMed
    Score: 0.019
  9. Recruiting older African American men to a cancer screening trial (the AAMEN Project). Gerontologist. 2003 Feb; 43(1):27-35.
    View in: PubMed
    Score: 0.018
  10. Perceptions of diabetes among patients in an urban health care system. Ethn Health. 2002 Nov; 7(4):243-54.
    View in: PubMed
    Score: 0.017
  11. Recruitment of African Americans with type 2 diabetes to a randomized controlled trial using three sources. Ethn Health. 2002 Nov; 7(4):267-78.
    View in: PubMed
    Score: 0.017
  12. Validation of the Hebrew version of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale. Parkinsonism Relat Disord. 2017 Dec; 45:7-12.
    View in: PubMed
    Score: 0.012
  13. Caffeine, creatine, GRIN2A and Parkinson's disease progression. J Neurol Sci. 2017 Apr 15; 375:355-359.
    View in: PubMed
    Score: 0.012
  14. Longer Duration of MAO-B Inhibitor Exposure is Associated with Less Clinical Decline in Parkinson's Disease: An?Analysis?of?NET-PD LS1. J Parkinsons Dis. 2017; 7(1):117-127.
    View in: PubMed
    Score: 0.012
  15. Gender-, age-, and race/ethnicity-based differential item functioning analysis of the movement disorder society-sponsored revision of the Unified Parkinson's disease rating scale. Mov Disord. 2016 12; 31(12):1865-1873.
    View in: PubMed
    Score: 0.012
  16. Religiosity in black and white older Americans: Measure adaptation, psychometric validation, and racial difference. Medicine (Baltimore). 2016 Sep; 95(37):e4257.
    View in: PubMed
    Score: 0.011
  17. Two Decades of ICU Utilization and Hospital Outcomes in a Comprehensive Cancer Center. Crit Care Med. 2016 May; 44(5):926-33.
    View in: PubMed
    Score: 0.011
  18. Association of transfusion red blood cell storage age and blood oxygenation, long-term neurologic outcome, and mortality in traumatic brain injury. J Trauma Acute Care Surg. 2015 Nov; 79(5):843-9.
    View in: PubMed
    Score: 0.011
  19. Antiphospholipid Antibodies and Recurrent Thrombotic Events: Persistence and Portfolio. Cerebrovasc Dis. 2015; 40(5-6):293-300.
    View in: PubMed
    Score: 0.011
  20. Effect of creatine monohydrate on clinical progression in patients with Parkinson disease: a randomized clinical trial. JAMA. 2015 Feb 10; 313(6):584-93.
    View in: PubMed
    Score: 0.010
  21. Handling missing values in the MDS-UPDRS. Mov Disord. 2015 Oct; 30(12):1632-8.
    View in: PubMed
    Score: 0.010
  22. Minocycline in rheumatoid arthritis. A 48-week, double-blind, placebo-controlled trial. MIRA Trial Group. Ann Intern Med. 1995 Jan 15; 122(2):81-9.
    View in: PubMed
    Score: 0.010
  23. An evaluation of differences in risk factors for individual types of surgical site infections after colon surgery. Surgery. 2014 Nov; 156(5):1253-60.
    View in: PubMed
    Score: 0.010
  24. Relationships among cognitive impairment, sleep, and fatigue in Parkinson's disease using the MDS-UPDRS. Parkinsonism Relat Disord. 2014 Nov; 20(11):1135-9.
    View in: PubMed
    Score: 0.010
  25. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet. 2014 Nov 29; 384(9958):1929-35.
    View in: PubMed
    Score: 0.010
  26. Measuring disease progression in early Parkinson disease: the National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) experience. JAMA Neurol. 2014 Jun; 71(6):710-6.
    View in: PubMed
    Score: 0.010
  27. Relationship between the MDS-UPDRS domains and the health-related quality of life of Parkinson's disease patients. Eur J Neurol. 2014 Mar; 21(3):519-24.
    View in: PubMed
    Score: 0.010
  28. The MDS-UPDRS Part II (motor experiences of daily living) resulted useful for assessment of disability in Parkinson's disease. Parkinsonism Relat Disord. 2013 Oct; 19(10):889-93.
    View in: PubMed
    Score: 0.009
  29. Assessing the non-motor symptoms of Parkinson's disease: MDS-UPDRS and NMS Scale. Eur J Neurol. 2015 Jan; 22(1):37-43.
    View in: PubMed
    Score: 0.009
  30. Expanded and independent validation of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS). J Neurol. 2013 Jan; 260(1):228-36.
    View in: PubMed
    Score: 0.009
  31. Application of beta regression to analyze ischemic stroke volume in NINDS rt-PA clinical trials. Neuroepidemiology. 2011; 37(2):73-82.
    View in: PubMed
    Score: 0.008
  32. Designing clinical trials of treatment for osteoporosis: recruitment and follow-up. Calcif Tissue Int. 1990 Dec; 47(6):327-31.
    View in: PubMed
    Score: 0.008
  33. Impact of belief in neuroprotection on therapeutic intervention in Parkinson's disease. Mov Disord. 2010 Jun 15; 25(8):1082-6.
    View in: PubMed
    Score: 0.007
  34. Risk of colorectal cancer among automotive pattern and model makers. J Occup Med. 1990 Jun; 32(6):541-6.
    View in: PubMed
    Score: 0.007
  35. Determinants of the timing of symptomatic treatment in early Parkinson disease: The National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) Experience. Arch Neurol. 2009 Sep; 66(9):1099-104.
    View in: PubMed
    Score: 0.007
  36. Patent foramen ovale, cardiac valve thickening, and antiphospholipid antibodies as risk factors for subsequent vascular events: the PICSS-APASS study. Stroke. 2009 Jul; 40(7):2337-42.
    View in: PubMed
    Score: 0.007
  37. Two pharmacy interventions to improve refill persistence for chronic disease medications: a randomized, controlled trial. Med Care. 2009 Jan; 47(1):32-40.
    View in: PubMed
    Score: 0.007
  38. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord. 2008 Nov 15; 23(15):2129-70.
    View in: PubMed
    Score: 0.007
  39. Mentoring in community-based participatory research: the RCMAR experience. Ethn Dis. 2007; 17(1 Suppl 1):S33-43.
    View in: PubMed
    Score: 0.006
  40. Association of serial biochemical markers with acute ischemic stroke: the National Institute of Neurological Disorders and Stroke recombinant tissue plasminogen activator Stroke Study. Stroke. 2006 Oct; 37(10):2508-13.
    View in: PubMed
    Score: 0.006
  41. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet. 2004 Mar 06; 363(9411):768-74.
    View in: PubMed
    Score: 0.005
  42. Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke. JAMA. 2004 Feb 04; 291(5):576-84.
    View in: PubMed
    Score: 0.005
  43. Lack of clinical significance of early ischemic changes on computed tomography in acute stroke. JAMA. 2001 Dec 12; 286(22):2830-8.
    View in: PubMed
    Score: 0.004
  44. Predicting prognosis after stroke: a placebo group analysis from the National Institute of Neurological Disorders and Stroke rt-PA Stroke Trial. Neurology. 2000 Oct 10; 55(7):952-9.
    View in: PubMed
    Score: 0.004
  45. Lower thrombolytic use for African Americans with myocardial infarction: an influence of clinical presentation? Am Heart J. 1999 Feb; 137(2):338-45.
    View in: PubMed
    Score: 0.003
  46. Social support among African-American adults with diabetes, Part 2: A review. J Natl Med Assoc. 1998 Jul; 90(7):425-32.
    View in: PubMed
    Score: 0.003
  47. Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke. NINDS rt-PA Stroke Study Group. Neurology. 1998 Apr; 50(4):883-90.
    View in: PubMed
    Score: 0.003
  48. Psychosocial correlates of healthful diets among male auto workers. Cancer Epidemiol Biomarkers Prev. 1998 Feb; 7(2):119-26.
    View in: PubMed
    Score: 0.003
  49. Health outcomes among African American and Caucasian adults following a randomized trial of an asthma education program. Ethn Health. 1997 Nov; 2(4):329-39.
    View in: PubMed
    Score: 0.003
  50. A cross sectional assessment of health status instruments in patients with rheumatoid arthritis participating in a clinical trial. Minocycline in Rheumatoid Arthritis Trial Group. J Rheumatol. 1997 Oct; 24(10):1910-5.
    View in: PubMed
    Score: 0.003
  51. Radiographic results from the Minocycline in Rheumatoid Arthritis (MIRA) Trial. J Rheumatol. 1997 Jul; 24(7):1295-302.
    View in: PubMed
    Score: 0.003
  52. Meaningful improvement criteria sets in a rheumatoid arthritis clinical trial. MIRA Trial Group. Minocycline in Rheumatoid Arthritis. Arthritis Rheum. 1997 Mar; 40(3):419-25.
    View in: PubMed
    Score: 0.003
  53. Rib enlargement in patients with chronic pleural disease. AJR Am J Roentgenol. 1996 Oct; 167(4):921-6.
    View in: PubMed
    Score: 0.003
  54. Recurrent cytogenetic abnormalities in squamous cell carcinomas of the head and neck region. Genes Chromosomes Cancer. 1994 Mar; 9(3):192-206.
    View in: PubMed
    Score: 0.002
  55. Age-related changes in glomerular volume and hydroxyproline content in rat and human. J Am Soc Nephrol. 1992 Jun; 2(12):1716-25.
    View in: PubMed
    Score: 0.002
  56. The cost and effectiveness of an education program for adults who have asthma. J Gen Intern Med. 1991 Sep-Oct; 6(5):401-7.
    View in: PubMed
    Score: 0.002
  57. A randomized trial of sodium fluoride as a treatment for postmenopausal osteoporosis. Osteoporos Int. 1991 Jun; 1(3):155-61.
    View in: PubMed
    Score: 0.002
  58. Measurement of vertebral area on spine x-rays in osteoporosis: reliability of digitizing techniques. J Bone Miner Res. 1990 Jul; 5(7):707-16.
    View in: PubMed
    Score: 0.002
  59. Identification of women at risk for developing postmenopausal osteoporosis with vertebral fractures: role of history and single photon absorptiometry. Bone Miner. 1989 Sep; 7(2):171-86.
    View in: PubMed
    Score: 0.002
  60. Recurrent femoral anastomotic aneurysms. A 30-year experience. Ann Surg. 1988 Oct; 208(4):401-9.
    View in: PubMed
    Score: 0.002
  61. Frequency and significance of cardiac arrhythmias in chronic obstructive lung disease. Chest. 1988 Jul; 94(1):44-8.
    View in: PubMed
    Score: 0.002
  62. Cerebral blood flow asymmetry in the detection of extracranial cerebrovascular disease. Stroke. 1988 Jul; 19(7):813-9.
    View in: PubMed
    Score: 0.002
  63. The porcine bioprosthetic valve. Twelve years later. J Thorac Cardiovasc Surg. 1985 Apr; 89(4):499-507.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.